Clinical Trial Detail

NCT ID NCT03166085
Title PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Nab-paclitaxel + PU-H71

Age Groups: adult senior

Additional content available in CKB BOOST